A Study of LY3502970 in Participants With Impaired and Normal Liver Function

Clinical trial NCT05882032 · COMPLETED

Trial details

NCT number: NCT05882032
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Hepatic Insufficiency

Start date: 2023-06-13
Primary completion: 2024-11-18
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.